Genetic Mutation Holds Promise for Cholesterol-Busting Drug

at 9:00 AM
 (Getty Images)

After two women with similar genetic mutations were found to have astoundingly low cholesterol, drug companies began racing to release a super-drug that mimics that cholesterol-destroying mutation. New York Times science writer Gina Kolata and the director of the National Heart, Lung, and Blood Institute, Dr. Gary Gibbons, discuss these findings, and whether a super-drug could make high cholesterol a thing of the past.

Guests:

Gina Kolata, science reporter for the New York Times

Dr. Gary Gibbons, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health

Sponsored

Sponsored

Volume
KQED Live
Live Stream
Log In ToPledge-Free Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.